Green Financial Statements From 2010 to 2024
| GTBIF Stock | USD 9.60 0.26 2.78% |
Check Green Thumb financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Green Thumb's main balance sheet or income statement drivers, such as , as well as many indicators such as . Green financial statements analysis is a perfect complement when working with Green Thumb Valuation or Volatility modules.
Green |
Green Thumb Industries OTC Stock Profit Margin Analysis
Green Thumb's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Green Thumb Profit Margin | 0.09 % |
Most of Green Thumb's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Green Thumb Industries is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Green Thumb Industries has a Profit Margin of 0.0859%. This is 100.77% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 106.76% lower than that of the firm.
Green Thumb Industries Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Green Thumb's current stock value. Our valuation model uses many indicators to compare Green Thumb value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Green Thumb competition to find correlations between indicators driving Green Thumb's intrinsic value. More Info.Green Thumb Industries is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 1.09 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Green Thumb's earnings, one of the primary drivers of an investment's value.About Green Thumb Financial Statements
Green Thumb stakeholders use historical fundamental indicators, such as Green Thumb's revenue or net income, to determine how well the company is positioned to perform in the future. Although Green Thumb investors may analyze each financial statement separately, they are all interrelated. For example, changes in Green Thumb's assets and liabilities are reflected in the revenues and expenses on Green Thumb's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Green Thumb Industries. Please read more on our technical analysis and fundamental analysis pages.
Green Thumb Industries Inc. engages in manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois. Green Thumb operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4000 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Green OTC Stock
Green Thumb financial ratios help investors to determine whether Green OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Green with respect to the benefits of owning Green Thumb security.